This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Miguel Forte, MD, Ph.D.
CEO at Zelluna Immunotherapy, Norway


Miguel Forte is the Chief Executive Officer of Zelluna Immunotherapy and currently Chief Commercialization Officer and Chair of the Commercialization Committee, International Society of Cellular Therapy. Formerly CMO, Bone Therapeutics SA and EVP and SVP of Clinical Development and Regulatory Affairs, COO and CMO of TxCell S.A. Miguel has extensive expertise in the regenerative medicine and cell therapy industries, as well as medical and regulatory affairs, ranging from leading early and late stage clinical trials to market authorization and the launch of new biologic products for various indications.

Agenda Sessions

  • Chairperson’s Opening Remarks